Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy.
Ann Surg Oncol. 2012 Nov;19(12):3849-55. doi: 10.1245/s10434-012-2439-7. Epub 2012 Jun 16.
Lymphadenectomy is important in the surgical treatment of apparent early epithelial ovarian cancers (eEOC); however, its extent is not well defined. We evaluated the role of systematic lymphadenectomy, the risk factors related with lymph node metastases, the implications, and the morbidity of comprehensive surgical staging.
We prospectively recruited 124 patients diagnosed with apparent eEOC [International Federation of Gynecology and Obstetrics (FIGO) stage I and II] between January 2003 and January 2011. Demographics, surgical procedures, morbidities, pathologic findings, and correlations with lymph node metastases were assessed.
A total of 111 patients underwent complete surgical staging, including lymphadenectomy, and were therefore analyzed. A median of 23 pelvic and 20 para-aortic nodes were removed. Node metastases were found in 15 patients (13.5 %). The para-aortic region was involved in 13 (86.6 %) of 15 cases. At univariate analysis, age, menopause, FIGO stage, grading, and laterality were found to be significant factors for lymph node metastases, while CA125 of >35 U/ml and positive cytology were not. No lymph node metastases were found in mucinous histotypes. At multivariate analysis, only bilaterality (p = 0.018) and menopause (p = 0.032) maintained a statistically significant association with lymph node metastases. Lymphadenectomy-related complications (lymphocyst formation and lymphorrhea) were found in 14.4 % patients.
The data of this prospective study demonstrate the prognostic value of lymphadenectomy in eEOC. Menopause, age, bilaterality, histology, and tumor grade are identifiable factors that can help the surgeon decide whether to perform comprehensive surgical staging with lymph node dissection. These parameters may be used in planning subsequent treatment.
淋巴结切除术在明显早期上皮性卵巢癌(eEOC)的外科治疗中很重要,但具体切除范围尚未明确。我们评估了系统淋巴结切除术的作用、与淋巴结转移相关的危险因素、全面手术分期的意义和发病率。
我们前瞻性招募了 2003 年 1 月至 2011 年 1 月期间诊断为明显 eEOC(国际妇产科联合会 [FIGO] 分期 I 期和 II 期)的 124 例患者。评估了患者的人口统计学资料、手术过程、发病率、病理发现以及与淋巴结转移的相关性。
共 111 例患者接受了完整的手术分期,包括淋巴结切除术,并对其进行了分析。中位数为 23 个盆腔和 20 个腹主动脉旁淋巴结被切除。15 例(13.5%)患者发现淋巴结转移。13 例(86.6%)转移发生在腹主动脉旁区域。单因素分析发现,年龄、绝经状态、FIGO 分期、分级和肿瘤侧别是淋巴结转移的显著因素,而 CA125>35 U/ml 和细胞学阳性则不是。黏液性组织类型未发现淋巴结转移。多因素分析仅发现双侧性(p=0.018)和绝经状态(p=0.032)与淋巴结转移有统计学显著关联。淋巴结切除术相关并发症(淋巴囊肿形成和淋巴漏)在 14.4%的患者中发生。
本前瞻性研究的数据表明,淋巴结切除术在 eEOC 中有预后价值。绝经状态、年龄、双侧性、组织学和肿瘤分级是可识别的因素,可帮助外科医生决定是否进行包括淋巴结清扫的全面手术分期。这些参数可用于规划后续治疗。